BAZ2-ICR
-
Catalog numberB1865-25
-
PricePlease ask
-
Size25 mg
-
-
Alternative_name4-(4-(1-methyl-1H-pyrazol-4-yl)-1-(2-(1-methyl-1H-pyrazol-4-yl)ethyl)-1H-imidazol-5-yl)benzonitrile; BAZ2ICR
-
DescriptionBAZ2-ICR is a small molecule inhibitor of BAZ2A (Kd = 109 nM; IC₅₀ = 130 nM) and BAZ2B (Kd = 170 nM; IC50 = 180 nM) bromodomains. It displays 15-fold selectivity for binding BAZ2A/B over CECR2 and >100-fold selectivity over all other bromodomains. BAZ2-ICR has been shown to displace BAZ2 bromodomains in living cells by demonstrating accelerated FRAP recovery at 1 µM in the BAZ2A FRAP assay.
-
CAS Number1665195-94-7
-
Structure AvailableYes
-
Molecular FormulaC₂₀H₁₉N₇
-
Molecular Weight357.41
-
Cell PermeableYes
-
Purity≥98% by HPLC
-
SolubilitiesDMSO (>15 mg/ml)
-
HandlingProtect from air and light
-
Tag LineA bromodomain inhibitor
-
Storage Condition-20°C
-
Shipping ConditionGel Pack
-
Shelf Life36 months
-
PubChem CID91654625
-
SMILESCN1C=C(C=N1)CCN2C=NC(=C2C3=CC=C(C=C3)C#N)C4=CN(N=C4)C
-
InChiInChI=1S/C20H19N7/c1-25-12-16(10-23-25)7-8-27-14-22-19(18-11-24-26(2)13-18)20(27)17-5-3-15(9-21)4-6-17/h3-6,10-14H,7-8H2,1-2H3
-
InChi KeyRRZVGDGTWNQAPW-UHFFFAOYSA-N
-
MSDS AvailableYes
-
Gene target
-
Short nameBAZ2-ICR
-
Alternative nameBAZ2-ICR
-